Tag: Tuberculosis
Shortened BDLC Regimen Not Noninferior for Drug-Resistant TB
Six or nine months of bedaquiline, delamanid, linezolid, and clofazimine was not noninferior to longer standard of care
COVID-19 Pandemic Yielded Indirect Increases in Disease Burden
Most predominant causes of increased DALY burden globally were seen for depressive and anxiety disorders, especially among women and girls
BCG Revaccination Does Not Provide Protection From Sustained Mycobacterium Tuberculosis Infection
Adverse events occurred more often in the BCG revaccination group, and most were due to injection-site reactions
Tuberculosis on the Rise Again in the United States
Preliminary data show 2024 rates were highest seen in more than 12 years
Three All-Oral Shortened Regimens Noninferior for Rifampin-Resistant TB
Noninferior efficacy seen for three all-oral regimens compared with standard therapy in intention-to-treat, per-protocol populations
Health Officials Alarmed by Tuberculosis Outbreak in Kansas
Local health officials are offering free TB testing to help control the outbreak
Shorter Treatment Regimens Recommended for Tuberculosis
Four-month regimen recommended for drug-susceptible TB and six-month regimen recommended for drug-resistant TB
Global TB Cases Hit Record High, TB Becomes Top Infectious Disease Killer
Tuberculosis continues to mostly affect people in Southeast Asia, Africa, and the Western Pacific
Persistent Disparities Seen by Race/Ethnicity in Incidence of TB
Incidence rate ratios as high as 14.2 among American Indian or Alaska Native females compared with non-Hispanic Whites
CDC: Tuberculosis Case Counts, Rates Increasing Since 2020
16 percent increase in TB cases seen in 2023 versus 2022, with the rate increased from 2.5 to 2.9 per 100,000
